| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0008 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |